Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject with a NSCL/P or CL/P of unknown etiology,

national health care insurance holders

Disqualifiers

Subject with a CL/P of known etiology,

Subject with a NSCL/P and an IRF6 mutation

Trial design

Design model

Single group

Treatments tested in this trial

  • identification of genetic factors

    Genetic

    Clinical questionnaire and analysis of genetic data obtained by exome high-throughput sequencing

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Identification of genetic factorsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Identification of genetic factors

Identification of genetic factors implicated in orofacial cleft using whole exome sequencing (WES).

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.